twoXAR is an artificial intelligence-driven drug discovery company. The company leverages its computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies, and progresses drug candidates to the clinic through industry and investor partnerships.

  • The convergence of big data, cloud computing, and artificial intelligence has allowed twoXAR to build a drug discovery platform that is orders of magnitude faster, cheaper, and more accurate than traditional approaches.


    twoXAR leverages its technology internally to build its own pipeline of therapeutic candidates across diseases as well as collaborate with biotechnology and pharmaceutical companies to jointly discover and develop novel drug candidates.​